Ontrak (OTRK) is a Top Pick for 2021 — and while many readers might not recognize the name, th...
Genuine Parts: A Real Value?
08/14/2020 5:00 am EST
Focus: HEALTHCARE
Genuine Parts (GPC) reported second-quarter earnings per share (EPS) of $1.32 vs. $1.47 in the prior year, observes Hilary Kramer, editor of Value Authority — and a participant in MoneyShow's Virtual Expo on August 18-20. Register for free here.
Results were $0.32 better than expectations, as the company aggressively cut costs relating to sales and administration in response to lower demand.
Revenues were down 14.2% in the quarter, or 13.7% when excluding the impact of acquisitions, divestitures and currency fluctuations.
On the conference call, the company indicated that July sales were positive, with automotive group sales up 6%.
While industrial group sales were still down by double-digit-percentages, the company expects the recent improvement in manufacturing data to flow to their operations.
I believe that GPC is managing the COVID-19 crisis well. The way that profitability held on, despite the sharp decline in sales in the quarter, was impressive.
While the company is still withholding guidance due to a high level of economic uncertainty, I believe that EPS can improve to $5 next year from an expected $4.50 this year.
Achieving this level of profitability can bring the stock close to my $100 target. GPC is a buy below $85. My target is $100. The 3.47% dividend yield will add to total returns.
Related Articles on HEALTHCARE
Regeneron (RGEN) is a leading biotechnology company; its science-driven approach has resulted in eig...
AbbVie (ABBV) is a pharmaceutical giant that was spun off from Abbott Laboratories (ABT) in 2013. Th...
After a frustrating 2020, Esperion Therapeutics (ESPR) is poised for a strong 2021; the firm's new C...